#edgeio
Explore tagged Tumblr posts
Text
BLIIoT EtherCAT Distributed Edge IO Module BL202 help Lithium Battery Production
Foreword
With the development of science and technology at any time, human beings pay more and more attention to the living environment, and the trend of decarbonization of environmentally friendly energy has accelerated. In this process, lithium batteries, as a mature environmentally friendly energy storage technology, are receiving widespread attention , and gradually become the main substitute for petrochemical energy. However, for the production of lithium batteries, it involves a very long and complicated production chain. From the perspective of the entire production chain, lithium battery production is a typical process production, that is, the process Basically, it is carried out continuously, and the production sequence is almost unchanged.
Lithium Battery Production Process
The production process of lithium batteries is divided into three stages: front, middle and back:
1. The purpose of the previous process is to process raw materials into pole pieces, and the core process is coating;
2. The purpose of the middle section is to process the pole piece into an unactivated cell, and complete the winding and liquid injection of the cell
3. The latter process is testing and packaging, and the core process is formation and volume separation.
The standard requirements of each link in the manufacturing process of lithium batteries will directly affect the cost, quality, safety and consistency of batteries. The production process of hammer batteries is divided into three stages: front, middle and back. The purpose of the front stage process is to process raw materials into pole pieces, the core process is coating, the purpose of the middle stage is to process pole pieces into inactive cells, the back stage process is to detect and package, and the core process is formation and capacity separation. The entire lithium battery production process is complex and the system is huge. There are many IO points, which require convenient debugging, high degree of standardization, many repeated modules, and then many and scattered data collection locations, so it is most suitable to use BLIIoT EtherCAT Distributed Edge I/O Module BL202.
BLIIoT EtherCAT Distributed Edge I/O Module BL202
The distributed I/O module provided for lithium battery equipment manufacturers and system integrators greatly improves the quality of the equipment by virtue of its advantages in operation and function, provides a strong boost for its rapid acquisition and feedback adjustment, and shortens the delivery time. Reduced overall costs. BLIIoT EtherCAT Distributed Edge I/O Module BL202 is a new IO expansion solution based on the EtherCAT protocol control system. Because of its high technical indicators, stable and reliable operation, it fully meets the needs of customers, and thus has won the favor of customers. It has been successfully applied to lithium battery production coating, rolling, slitting, coiling Around and other processes.
Applications
Coating Machine
The main purpose of coating is to evenly coat the slurry on the surface of the positive and negative electrodes. This case realizes digitization, unwinding, coating, drying and winding are all completed automatically
Solution Topology
Solution advantage
Tension control: Different sensors will be used for tension control, such as ultrasonic probes, floating rollers, etc. BLIIoT EtherCAT Distributed Edge I/O Module BL202 can realize stable wiring and plug-and-play between these sensors and PLC, and there is no need to change the wiring at any time to replace the module.
Stable transmission: accurate coating speed makes the slurry utilization rate high and can maintain the production of high-quality pole pieces. Its high-speed system bus provides fast response times in milliseconds.
Resistant to harsh industrial conditions: In the face of on-site temperature changes, the wide temperature design of BLIIoT EtherCAT Distributed Edge I/O Module BL202 can always maintain stable work, and the functions can be used smoothly.
BLIIoT EtherCAT Distributed Edge I/O Module BL202 Helps Lithium Battery Production
The BLIIoT EtherCAT Distributed Edge I/O Module BL202 brings flexibility and convenience in design details, which is also an important idea for us to develop and optimize products. In terms of structure, with the plug-in design, equipment manufacturers can freely combine IO modules according to their needs, which saves up to 50% of the time compared with traditional wiring methods. And the clutch is small in size and does not take up space. In the installation, the guide rail installation is adopted, which is simple and convenient.
More information about the BLIIoT EtherCAT Distributed Edge I/O Module BL202: https://www.bliiot.com/ethercat-io-module-p00349p1.html
0 notes
Text
BLIIoT Ethernet Remote ProfiNet Edge Distributed I/O Coupler EdgeIO BL200PN
ProfiNet IO Coupler BL200PN integrates a Network controller for fieldbus and Real-Time Ethernet slaves, suitable for creating a high-speed, stable and reliable Industrial Real-Time Ethernet networks and profinet fieldbus network.
#iot#iiot#profinet#edgecomputing#iomodule#industria40#industrialautomation#ethernet#BLIIoT#BLIIoT Applications
0 notes
Text
Keith Teare Joins MediChain as an Advisor – a Headline-Worthy News in the Blockchain ICO Market
All eyes are on MediChain now as Keith Teare, a globally-recognized serial entrepreneur with big ideas and an impressive record of winning high returns for the investors joins the MediChain Advisory Board. The recent addition of Teare in MediChain’s team is being seen as one of the greatest achievements of the company, since the executive chairman of Accelerated Digital Ventures has previously advised on the successful ICOBox, Crypterium, FluzFluz and EnergiMine ICOs.
Stating his views about MediChain, Teare said,
“Medichain represents a bold attempt to leverage the blockchain for patient records. It has long been recognized that patient-centric records represent a goal that would make health care far more efficient and enable doctors the benefit of seeing a patient’s entire medical history. Medichain is executing on that vision. Unlike others, it is also using machine learning to allow insights that can be gleaned from aggregate data. If it reaches its potential this will be a significant contribution to humanity.”
About Keith Teare & His Successful Journey
Keith is the co-founder of Archimedes Ventures where Mike Arrington’s TechCrunch was born and incubated along with Edgeio. He and Arrington were co-founders in both companies. Teare ran Edgeio and Arrington ran TechCrunch. He was the founder and CEO of RealNames Corporation and earlier the co-founder and CTO of EasyNet – the first European ISP.
Working at RealNames, he created a multi-lingual naming system, with distinct national namespaces, sitting on top of the DNS. It used natural language keywords, mapped to URIs to allow native language navigation. Teare raised more than $130 million in venture funding and filed for an IPO in 1999. After negotiating a worldwide agreement to include RealNames in the Microsoft browser in early 2000, the company had an implied valuation of more than $1.5 billion. By 2002, it was responsible for over 1 billion keyword navigations per quarter. It had agreements in Japan, China, and Korea, and was responsible for supporting the nascent multi-lingual DNS system run by Verisign.
He was the Seed funder and chair of NetNames, the founder of Clerkswell — a leading UK systems integrator as well as the Co-founder of CYBERIA, the world’s first Internet Café. Teare also served fotopedia being its founding board member.
Keith Teare Foresees Blockchain as the Future of Most of the Industries
Being a blockchain enthusiast and a start-up expert, Keith Teare strongly believes that moments of change represent the best time to invest in tech. His prediction is based on the fact that blockchain is going to be just everywhere in near future, and that’s what the transition in his professional journey shows:
In 1981, he was focused on networking and shared data.
In 1994, he initiated to harness the power of the Internet (EasyNet).
In 1997, he turned to web services (RealNames).
In 2005, his focus was on Web 2.0 (Archimedes Ventures, Edgeio, and TechCrunch).
In 2010, he extensively worked on mobile (Archimedes Labs, Quixey, M.Dot).
In 2018, he is all set to exploit the Blockchain (Accelerated Digital Ventures and MediChain).
MediChain, leveraging the advisor-ship of Keith Teare, is planning ground-breaking developments on the platform in near future.
To know more about MediChain and Keith Teare being its advisor, please visit https://medichain.online/
The post Keith Teare Joins MediChain as an Advisor – a Headline-Worthy News in the Blockchain ICO Market appeared first on NewsBTC.
from CryptoCracken SMFeed http://ift.tt/2GdQhzD via IFTTT
0 notes
Text
Keith Teare Joins MediChain as an Advisor – a Headline-Worthy News in the Blockchain ICO Market
All eyes are on MediChain now as Keith Teare, a globally-recognized serial entrepreneur with big ideas and an impressive record of winning high returns for the investors joins the MediChain Advisory Board. The recent addition of Teare in MediChain’s team is being seen as one of the greatest achievements of the company, since the executive chairman of Accelerated Digital Ventures has previously advised on the successful ICOBox, Crypterium, FluzFluz and EnergiMine ICOs.
Stating his views about MediChain, Teare said,
“Medichain represents a bold attempt to leverage the blockchain for patient records. It has long been recognized that patient-centric records represent a goal that would make health care far more efficient and enable doctors the benefit of seeing a patient’s entire medical history. Medichain is executing on that vision. Unlike others, it is also using machine learning to allow insights that can be gleaned from aggregate data. If it reaches its potential this will be a significant contribution to humanity.”
About Keith Teare & His Successful Journey
Keith is the co-founder of Archimedes Ventures where Mike Arrington’s TechCrunch was born and incubated along with Edgeio. He and Arrington were co-founders in both companies. Teare ran Edgeio and Arrington ran TechCrunch. He was the founder and CEO of RealNames Corporation and earlier the co-founder and CTO of EasyNet – the first European ISP.
Working at RealNames, he created a multi-lingual naming system, with distinct national namespaces, sitting on top of the DNS. It used natural language keywords, mapped to URIs to allow native language navigation. Teare raised more than $130 million in venture funding and filed for an IPO in 1999. After negotiating a worldwide agreement to include RealNames in the Microsoft browser in early 2000, the company had an implied valuation of more than $1.5 billion. By 2002, it was responsible for over 1 billion keyword navigations per quarter. It had agreements in Japan, China, and Korea, and was responsible for supporting the nascent multi-lingual DNS system run by Verisign.
He was the Seed funder and chair of NetNames, the founder of Clerkswell — a leading UK systems integrator as well as the Co-founder of CYBERIA, the world’s first Internet Café. Teare also served fotopedia being its founding board member.
Keith Teare Foresees Blockchain as the Future of Most of the Industries
Being a blockchain enthusiast and a start-up expert, Keith Teare strongly believes that moments of change represent the best time to invest in tech. His prediction is based on the fact that blockchain is going to be just everywhere in near future, and that’s what the transition in his professional journey shows:
In 1981, he was focused on networking and shared data.
In 1994, he initiated to harness the power of the Internet (EasyNet).
In 1997, he turned to web services (RealNames).
In 2005, his focus was on Web 2.0 (Archimedes Ventures, Edgeio, and TechCrunch).
In 2010, he extensively worked on mobile (Archimedes Labs, Quixey, M.Dot).
In 2018, he is all set to exploit the Blockchain (Accelerated Digital Ventures and MediChain).
MediChain, leveraging the advisor-ship of Keith Teare, is planning ground-breaking developments on the platform in near future.
To know more about MediChain and Keith Teare being its advisor, please visit https://medichain.online/
The post Keith Teare Joins MediChain as an Advisor – a Headline-Worthy News in the Blockchain ICO Market appeared first on NewsBTC.
from Cryptocracken WP http://ift.tt/2GdQhzD via IFTTT
0 notes
Text
Keith Teare Joins MediChain as an Advisor – a Headline-Worthy News in the Blockchain ICO Market
All eyes are on MediChain now as Keith Teare, a globally-recognized serial entrepreneur with big ideas and an impressive record of winning high returns for the investors joins the MediChain Advisory Board. The recent addition of Teare in MediChain’s team is being seen as one of the greatest achievements of the company, since the executive chairman of Accelerated Digital Ventures has previously advised on the successful ICOBox, Crypterium, FluzFluz and EnergiMine ICOs.
Stating his views about MediChain, Teare said,
“Medichain represents a bold attempt to leverage the blockchain for patient records. It has long been recognized that patient-centric records represent a goal that would make health care far more efficient and enable doctors the benefit of seeing a patient’s entire medical history. Medichain is executing on that vision. Unlike others, it is also using machine learning to allow insights that can be gleaned from aggregate data. If it reaches its potential this will be a significant contribution to humanity.”
About Keith Teare & His Successful Journey
Keith is the co-founder of Archimedes Ventures where Mike Arrington’s TechCrunch was born and incubated along with Edgeio. He and Arrington were co-founders in both companies. Teare ran Edgeio and Arrington ran TechCrunch. He was the founder and CEO of RealNames Corporation and earlier the co-founder and CTO of EasyNet – the first European ISP.
Working at RealNames, he created a multi-lingual naming system, with distinct national namespaces, sitting on top of the DNS. It used natural language keywords, mapped to URIs to allow native language navigation. Teare raised more than $130 million in venture funding and filed for an IPO in 1999. After negotiating a worldwide agreement to include RealNames in the Microsoft browser in early 2000, the company had an implied valuation of more than $1.5 billion. By 2002, it was responsible for over 1 billion keyword navigations per quarter. It had agreements in Japan, China, and Korea, and was responsible for supporting the nascent multi-lingual DNS system run by Verisign.
He was the Seed funder and chair of NetNames, the founder of Clerkswell — a leading UK systems integrator as well as the Co-founder of CYBERIA, the world’s first Internet Café. Teare also served fotopedia being its founding board member.
Keith Teare Foresees Blockchain as the Future of Most of the Industries
Being a blockchain enthusiast and a start-up expert, Keith Teare strongly believes that moments of change represent the best time to invest in tech. His prediction is based on the fact that blockchain is going to be just everywhere in near future, and that’s what the transition in his professional journey shows:
In 1981, he was focused on networking and shared data.
In 1994, he initiated to harness the power of the Internet (EasyNet).
In 1997, he turned to web services (RealNames).
In 2005, his focus was on Web 2.0 (Archimedes Ventures, Edgeio, and TechCrunch).
In 2010, he extensively worked on mobile (Archimedes Labs, Quixey, M.Dot).
In 2018, he is all set to exploit the Blockchain (Accelerated Digital Ventures and MediChain).
MediChain, leveraging the advisor-ship of Keith Teare, is planning ground-breaking developments on the platform in near future.
To know more about MediChain and Keith Teare being its advisor, please visit https://medichain.online/
The post Keith Teare Joins MediChain as an Advisor – a Headline-Worthy News in the Blockchain ICO Market appeared first on NewsBTC.
from Cryptocracken Tumblr http://ift.tt/2GdQhzD via IFTTT
0 notes